alprazolam and midazolam
alprazolam has been researched along with midazolam in 47 studies
Research
Studies (47)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (4.26) | 18.7374 |
1990's | 4 (8.51) | 18.2507 |
2000's | 18 (38.30) | 29.6817 |
2010's | 17 (36.17) | 24.3611 |
2020's | 6 (12.77) | 2.80 |
Authors
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Abraham, MH; Acree, WE; Ibrahim, A | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H | 1 |
Bracher, F; Fedorov, O; Filippakopoulos, P; Keller, M; Knapp, S; Morgenstern, O; Picaud, S; Wrobel, M | 1 |
Artursson, P; Mateus, A; Matsson, P | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Loeffler, PM | 1 |
Anderson, BJ; Brown, TC; Exarchos, H; Lee, K | 1 |
Jones, CE; Martinez, LA; Merritt, GJ; Wians, FH | 1 |
DiMicco, JA | 1 |
Adnet, P; Boittiaux, P; Forget, AP; Loeb, P; Mille, FX | 1 |
Balian, JD; Flockhart, DA; Yuan, R | 1 |
Greenblatt, DJ; Harmatz, JS; Poku, JW; Shader, RI; von Moltke, LL; Warrington, JS | 1 |
Cantrell, VE; Eckstein, J; Hall, SD; Hamman, MA; Jones, DR; Ring, BJ; Ruterbories, K; Williams, JA; Wrighton, SA | 1 |
Alegret, C; Cammu, G; De Witte, JL; Sessler, DI | 1 |
Kanbori, M; Kato, M; Kumaki, Y; Nakahara, Y; Toyo'oka, T | 1 |
Kozierowski, T; Małysz, A; Ruciński, M; Rzymski, S; Wołowicka, L | 1 |
Masica, AL; Mayo, G; Wilkinson, GR | 1 |
Benet, LZ | 1 |
Dickson, SJ; Irving, RC | 1 |
Galetin, A; Hallifax, D; Houston, JB | 1 |
Mandrioli, R; Mercolini, L; Raggi, MA | 1 |
Hanioka, N; Kuze, J; Morisaki, K; Mutoh, T; Nakura, H; Narimatsu, S; Takenaka, T | 1 |
Gunn, J; Kriger, S; Terrell, AR | 1 |
Castell, JV; Donato, MT; Gomez-Lechón, MJ; Hallifax, D; Houston, JB; Lahoz, A; Picazo, L | 1 |
Barter, ZE; Cubitt, HE; Howgate, EM; Rostami-Hodjegan, A; Yeo, KR | 1 |
Christianson, CD; Johnson, CJ; Laine, DF; Needham, SR; Sheaff, CN; Zimmer, JS | 1 |
Houjo, T; Ishigai, M; Kato, M; Ogawa, K | 1 |
Ishigai, M; Kato, M; Mitsui, T; Miyake, T; Nagao, S; Nemoto, T; Ogawa, K; Yamada, H | 1 |
Boulenc, X; Donazzolo, Y; Hermabessière, S; Martin, V; Nicolas, O; Ollier, C; Zobouyan, I | 1 |
Inoue, T; Ishii, S; Nakanishi, K; Sasaki, E; Uehara, S; Uno, Y; Yamazaki, H | 1 |
Dang, H; Kaufman, DL; Middleton, B; Tian, J | 1 |
Adiwidjaja, J; Boddy, AV; McLachlan, AJ | 1 |
Hasegawa, M; Tahara, H; Watanabe, M | 1 |
Chan, TS; Raymond, K; Scaringella, YS; Taub, ME | 1 |
Madsen, BK; Møller, AM; Rosenberg, J; Zetner, D | 1 |
Araújo, JO; Bergamaschi, CC; de Andrade, NK; Guimarães, CC; Lopes, LC; Motta, RHL; Ramacciato, JC | 1 |
Cook, JM; Duke, AN; Knutson, DE; Platt, DM; Rowlett, JK; Sharmin, D; Tiruveedhula, VVNPB | 1 |
Gui, L; Hu, Y; Jia, W; Lan, K; Liu, C; Miao, J; Wang, C; Wei, W; Wu, Q; Zeng, W | 1 |
Morikuni, S; Murayama, N; Noda, Y; Uno, Y; Yamazaki, H | 1 |
Reviews
6 review(s) available for alprazolam and midazolam
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Oral benzodiazepines and conscious sedation: a review.
Topics: Administration, Oral; Alprazolam; Ambulatory Surgical Procedures; Anti-Anxiety Agents; Conscious Sedation; Diazepam; Flurazepam; Humans; Lorazepam; Midazolam; Oxazepam; Premedication; Receptors, GABA-A; Temazepam; Triazolam | 1992 |
Pharmacokinetic and pharmacodynamic consequences of metabolism-based drug interactions with alprazolam, midazolam, and triazolam.
Topics: Alprazolam; Anti-Anxiety Agents; Data Collection; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Humans; Itraconazole; Ketoconazole; Midazolam; Triazolam | 1999 |
Benzodiazepine metabolism: an analytical perspective.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Azepines; Benzodiazepines; Bromazepam; Chromatography, High Pressure Liquid; Diazepam; Humans; Lorazepam; Mass Spectrometry; Midazolam; Triazolam | 2008 |
Melatonin for preoperative and postoperative anxiety in adults.
Topics: Adult; Aged; Aged, 80 and over; Alprazolam; Anti-Anxiety Agents; Anxiety; Bias; Clonidine; Drug Administration Schedule; Humans; Melatonin; Midazolam; Middle Aged; Oxazepam; Postoperative Care; Postoperative Complications; Preoperative Care; Publication Bias; Randomized Controlled Trials as Topic; Surgical Procedures, Operative | 2020 |
Effectiveness and safety of oral sedation in adult patients undergoing dental procedures: a systematic review.
Topics: Adult; Alprazolam; Anesthesia; Benzodiazepines; Diazepam; Humans; Midazolam | 2021 |
Trials
5 trial(s) available for alprazolam and midazolam
Article | Year |
---|---|
Oral premedication in children: a comparison of chloral hydrate, diazepam, alprazolam, midazolam and placebo for day surgery.
Topics: Administration, Oral; Alprazolam; Ambulatory Surgical Procedures; Anesthesia Recovery Period; Attitude; Child Behavior; Child, Preschool; Chloral Hydrate; Diazepam; Double-Blind Method; Female; Humans; Infant; Male; Midazolam; Placebos; Preanesthetic Medication; Random Allocation; Time Factors | 1990 |
Preoperative alprazolam reduces anxiety in ambulatory surgery patients: a comparison with oral midazolam.
Topics: Administration, Oral; Adult; Alprazolam; Ambulatory Surgical Procedures; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Humans; Midazolam; Premedication; Psychomotor Performance | 2002 |
[Perioperative sedation and analgesia for complications from arthroscopy and arthrotomy of the knee joint].
Topics: Administration, Oral; Alprazolam; Analgesia; Arthroscopy; Bupivacaine; Conscious Sedation; Epinephrine; Female; Fentanyl; Humans; Knee Joint; Lidocaine; Male; Midazolam; Pain Measurement; Pain, Postoperative; Patient Satisfaction; Preanesthetic Medication; Premedication | 2001 |
In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam.
Topics: Administration, Oral; Adult; Alprazolam; Anti-Anxiety Agents; Aryl Hydrocarbon Hydroxylases; Benzodiazepines; Biological Availability; Cytochrome P-450 CYP3A; Female; Humans; Male; Midazolam; Oxidoreductases, N-Demethylating; Triazolam | 2004 |
CYP3A4-based drug-drug interaction: CYP3A4 substrates' pharmacokinetic properties and ketoconazole dose regimen effect.
Topics: Adolescent; Adult; Alprazolam; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Humans; Ketoconazole; Male; Midazolam; Substrate Specificity; Young Adult | 2016 |
Other Studies
36 other study(ies) available for alprazolam and midazolam
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution | 2011 |
Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family.
Topics: Alprazolam; Benzazepines; Benzodiazepines; Cell Cycle Proteins; GABA Modulators; Humans; Midazolam; Models, Molecular; Nuclear Proteins; Protein Interaction Maps; Protein Structure, Tertiary; Transcription Factors | 2012 |
A high-throughput cell-based method to predict the unbound drug fraction in the brain.
Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
Benzodiazepines identified by capillary gas chromatography-mass spectrometry, with specific ion screening used to detect benzophenone derivatives.
Topics: Alprazolam; Benzodiazepines; Benzophenones; Forensic Medicine; Gas Chromatography-Mass Spectrometry; Humans; Hydrolysis; Immunoenzyme Techniques; Midazolam; Triazolam | 1989 |
Evidence for control of cardiac vagal tone by benzodiazepine receptors.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Atropine; Chlordiazepoxide; Flumazenil; Heart; Heart Rate; Male; Midazolam; Rats; Rats, Inbred Strains; Receptors, GABA-A; Vagus Nerve | 1987 |
[Benzodiazepine withdrawal presenting as pseudo-surgical abdominal pain].
Topics: Abdomen, Acute; Adult; Alprazolam; Anti-Anxiety Agents; Bromazepam; Diagnosis, Differential; Headache; Humans; Hydroxyzine; Male; Midazolam; Self Administration; Substance Withdrawal Syndrome; Substance-Related Disorders; Truth Disclosure; Vomiting | 1997 |
Effects of age on in vitro midazolam biotransformation in male CD-1 mouse liver microsomes.
Topics: Age Factors; Alprazolam; Animals; Anti-Anxiety Agents; Aryl Hydrocarbon Hydroxylases; Biotransformation; Blotting, Western; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; In Vitro Techniques; Ketoconazole; Male; Mice; Microsomes, Liver; Midazolam; Oxidoreductases, N-Demethylating | 2000 |
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.
Topics: Alprazolam; Aryl Hydrocarbon Hydroxylases; Biotransformation; Clarithromycin; Coumarins; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Cytochromes b5; Diltiazem; Estradiol; Humans; In Vitro Techniques; Kinetics; Microsomes, Liver; Midazolam; Nifedipine; Tamoxifen; Testosterone; Triazolam | 2002 |
Determination of hypnotic benzodiazepines (alprazolam, estazolam, and midazolam) and their metabolites in rat hair and plasma by reversed-phase liquid-chromatography with electrospray ionization mass spectrometry.
Topics: Alprazolam; Animals; Benzodiazepines; Chromatography, High Pressure Liquid; Estazolam; Hair; Male; Midazolam; Rats; Spectrometry, Mass, Electrospray Ionization | 2003 |
There are no useful CYP3A probes that quantitatively predict the in vivo kinetics of other CYP3A substrates and no expectation that one will be found.
Topics: Alprazolam; Benzodiazepines; Biopharmaceutics; Chemistry, Pharmaceutical; Cytochrome P-450 CYP3A; Drug Design; Humans; Kinetics; Midazolam; Molecular Probes; Protein Binding; Solubility; Triazolam | 2005 |
The detection of sedatives in hair and nail samples using tandem LC-MS-MS.
Topics: Adult; Aged; Aged, 80 and over; Alprazolam; Azabicyclo Compounds; Benzodiazepines; Chromatography, Liquid; Clobazam; Clonazepam; Diazepam; Female; Forensic Pathology; Hair; Humans; Hypnotics and Sedatives; Male; Mass Spectrometry; Midazolam; Middle Aged; Nails; Oxazepam; Piperazines; Predictive Value of Tests; Rape; Temazepam; Triazolam | 2007 |
Prediction of metabolic clearance using fresh human hepatocytes: comparison with cryopreserved hepatocytes and hepatic microsomes for five benzodiazepines.
Topics: Alprazolam; Benzodiazepines; Cell Survival; Cells, Cultured; Cryopreservation; Cytochrome P-450 CYP3A; Diazepam; Flunitrazepam; Hepatocytes; Humans; Metabolic Clearance Rate; Microsomes, Liver; Midazolam; Substrate Specificity; Triazolam | 2008 |
Separate evaluation of intestinal and hepatic metabolism of three benzodiazepines in rats with cannulated portal and jugular veins: comparison with the profile in non-cannulated mice.
Topics: Administration, Oral; Alprazolam; Animals; Benzodiazepines; Biological Availability; Catheterization; Intestinal Mucosa; Jugular Veins; Liver; Male; Mice; Mice, Inbred BALB C; Midazolam; Portal Vein; Rats; Rats, Sprague-Dawley; Triazolam | 2009 |
Simultaneous determination and quantification of 12 benzodiazepines in serum or whole blood using UPLC/MS/MS.
Topics: Alprazolam; Benzodiazepines; Chlordiazepoxide; Chromatography, Liquid; Clonazepam; Flunitrazepam; Humans; Lorazepam; Midazolam; Nordazepam; Oxazepam; Reproducibility of Results; Tandem Mass Spectrometry | 2010 |
Metabolite formation kinetics and intrinsic clearance of phenacetin, tolbutamide, alprazolam, and midazolam in adenoviral cytochrome P450-transfected HepG2 cells and comparison with hepatocytes and in vivo.
Topics: Adenoviridae; Alprazolam; Base Sequence; Cell Line; Cytochrome P-450 Enzyme System; DNA Primers; Hepatocytes; Humans; Midazolam; Phenacetin; Tolbutamide | 2010 |
Sources of interindividual variability in IVIVE of clearance: an investigation into the prediction of benzodiazepine clearance using a mechanistic population-based pharmacokinetic model.
Topics: Alprazolam; Benzodiazepines; Cytochrome P-450 CYP3A; Humans; Kinetics; Liver; Metabolic Clearance Rate; Midazolam; Triazolam | 2011 |
Use of conventional bioanalytical devices to automate DBS extractions in liquid-handling dispensing tips.
Topics: Alprazolam; Automation; Chromatography, High Pressure Liquid; Dried Blood Spot Testing; Humans; Midazolam; Tandem Mass Spectrometry | 2011 |
A new approach to predicting human hepatic clearance of CYP3A4 substrates using monkey pharmacokinetic data.
Topics: Alprazolam; Animals; Cytochrome P-450 CYP3A; Diltiazem; Humans; Liver; Macaca fascicularis; Midazolam; Tacrolimus | 2013 |
A useful model capable of predicting the clearance of cytochrome 3A4 (CYP3A4) substrates in humans: validity of CYP3A4 transgenic mice lacking their own Cyp3a enzymes.
Topics: Alprazolam; Animals; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Felodipine; Humans; Male; Mice; Mice, Transgenic; Microsomes, Liver; Midazolam; Nifedipine; Nitrendipine; Quinidine | 2014 |
Marmoset Cytochrome P450 3A4 Ortholog Expressed in Liver and Small-Intestine Tissues Efficiently Metabolizes Midazolam, Alprazolam, Nifedipine, and Testosterone.
Topics: Adolescent; Adult; Aged; Alprazolam; Animals; Callithrix; Cytochrome P-450 CYP3A; Female; Humans; Intestine, Small; Liver; Macaca fascicularis; Male; Microsomes; Midazolam; Middle Aged; Multigene Family; Nifedipine; Pharmaceutical Preparations; Phylogeny; Sequence Alignment; Sequence Homology, Amino Acid; Species Specificity; Testosterone; Young Adult | 2017 |
Clinically applicable GABA receptor positive allosteric modulators promote ß-cell replication.
Topics: Allosteric Regulation; Alprazolam; Animals; Benzodiazepines; Carrier Proteins; Cell Division; Cell Proliferation; Clonazepam; GABA Modulators; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Humans; Insulin-Secreting Cells; Islets of Langerhans; Mice; Midazolam; Rats; Receptors, GABA-A | 2017 |
Physiologically Based Pharmacokinetic Modelling of Hyperforin to Predict Drug Interactions with St John's Wort.
Topics: Adult; Alprazolam; Antineoplastic Agents; Computer Simulation; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Female; Herb-Drug Interactions; Humans; Hypericum; Imatinib Mesylate; Intestinal Mucosa; Liver; Male; Midazolam; Middle Aged; Models, Biological; Phloroglucinol; Terpenes | 2019 |
A comparative study for detecting CYP3A induction by CYP3A probe drugs and endogenous markers in cynomolgus monkeys.
Topics: Alprazolam; Animals; Area Under Curve; Biomarkers; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Dose-Response Relationship, Drug; Drug Interactions; Hydrocortisone; Hydroxycholesterols; Macaca fascicularis; Male; Midazolam; Rifampin; Triazolam | 2019 |
Evaluation of Erythromycin as a Tool to Assess CYP3A Contribution of Low Clearance Compounds in a Long-Term Hepatocyte Culture.
Topics: Adult; Alprazolam; Cells, Cultured; Coculture Techniques; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Evaluation, Preclinical; Erythromycin; Female; Glucuronosyltransferase; Hepatobiliary Elimination; Hepatocytes; Humans; Male; Midazolam; Middle Aged; Primary Cell Culture; Rifampin; Time Factors | 2020 |
Tolerance and dependence following chronic alprazolam treatment in rhesus monkeys: Role of GABA
Topics: Alprazolam; Animals; Benzodiazepines; Drug Tolerance; Female; Macaca mulatta; Midazolam; Receptors, GABA-A; Substance Withdrawal Syndrome; Zolpidem | 2021 |
Reevaluate In Vitro CYP3A Index Reactions of Benzodiazepines and Steroids between Humans and Dogs.
Topics: Alprazolam; Animals; Benzodiazepines; Cytochrome P-450 CYP3A; Deoxycholic Acid; Dogs; Humans; Hydroxylation; Kinetics; Microsomes, Liver; Midazolam; Protein Isoforms; Species Specificity; Steroids; Triazolam | 2022 |
Liver microsomal cytochrome P450 3A-dependent drug oxidation activities in individual dogs.
Topics: Alprazolam; Animals; Cytochrome P-450 CYP3A; Dogs; Estradiol; Hydroxylation; Liver; Microsomes, Liver; Midazolam; Nifedipine; Rats; RNA, Messenger | 2023 |